Wei Tao

32.5k total citations · 27 hit papers
273 papers, 26.1k citations indexed

About

Wei Tao is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Wei Tao has authored 273 papers receiving a total of 26.1k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Biomedical Engineering, 110 papers in Molecular Biology and 72 papers in Biomaterials. Recurrent topics in Wei Tao's work include Nanoplatforms for cancer theranostics (101 papers), RNA Interference and Gene Delivery (65 papers) and Nanoparticle-Based Drug Delivery (58 papers). Wei Tao is often cited by papers focused on Nanoplatforms for cancer theranostics (101 papers), RNA Interference and Gene Delivery (65 papers) and Nanoparticle-Based Drug Delivery (58 papers). Wei Tao collaborates with scholars based in China, United States and South Korea. Wei Tao's co-authors include Na Kong, Omid C. Farokhzad, Xiaoyuan Ji, Jinjun Shi, Lin Mei, Jiang Ouyang, Nitin Joshi, Xiaowei Zeng, Han Zhang and Dan Peer and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Wei Tao

266 papers receiving 25.9k citations

Hit Papers

Cellular uptake of nanoparticles: journey inside the cell 2016 2026 2019 2022 2017 2018 2016 2018 2019 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cellular uptake of nanoparticles: journey inside the cell
    2017 2.1k citations Wei Tao, Omid C. Farokhzad et al. profile →
  2. Progress and challenges towards targeted delivery of cancer therapeutics
    2018 1.7k citations Wei Tao et al. profile →
  3. Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics
    2016 799 citations Wei Tao, Xianbing Zhu et al. profile →
  4. Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments
    2018 533 citations Wei Tao, Xiaoyuan Ji et al. Advanced Science profile →
  5. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications
    2019 530 citations Wei Tao, Na Kong et al. profile →
  6. Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy
    2017 488 citations Wei Tao, Xiaoyuan Ji et al. profile →
  7. ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
    2017 431 citations Xiaoding Xu, Phei Er Saw et al. profile →
  8. A Novel Top‐Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging‐Guided Cancer Therapy
    2018 404 citations Xiaoyuan Ji, Na Kong et al. profile →
  9. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
    2021 370 citations Wei Chen, Jinjun Shi et al. profile →
  10. Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics
    2018 360 citations Wei Tao, Xiaoyuan Ji et al. profile →
  11. The landscape of mRNA nanomedicine
    2022 339 citations Xiangang Huang, Na Kong et al. profile →
  12. In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment
    2020 308 citations Jiang Ouyang, Xiaoyuan Ji et al. profile →
  13. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy
    2020 303 citations Jiang Ouyang, Xiaoyuan Ji et al. profile →
  14. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging
    2022 294 citations Jiang Ouyang, Angel Xie et al. profile →
  15. mRNA-based cancer therapeutics
    2023 290 citations Chuang LIU, Xiangang Huang et al. profile →
  16. Capturing functional two-dimensional nanosheets from sandwich-structure vermiculite for cancer theranostics
    2021 279 citations Xiaoyuan Ji, Chuang LIU et al. profile →
  17. Biomaterials and nanomedicine for bone regeneration: Progress and future prospects
    2021 212 citations Jun Zhou, Dylan Neal Patel et al. profile →
  18. Efferocytosis induces macrophage proliferation to help resolve tissue injury
    2021 209 citations Chuang LIU, Na Kong et al. profile →
  19. Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy
    2022 194 citations Jiang Ouyang, Wei Chen et al. profile →
  20. Emerging mRNA technologies: delivery strategies and biomedical applications
    2022 175 citations Zhongmin Tang, Xiangang Huang et al. profile →
  21. Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
    2022 156 citations Xiangang Huang, Wei Tao et al. Science Advances profile →
  22. Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity
    2023 146 citations Yongjiang Li, Wei Chen et al. profile →
  23. Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota
    2023 135 citations Jiang Ouyang, Yongjiang Li et al. profile →
  24. Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
    2022 128 citations Na Kong, Junqing Wang et al. profile →
  25. Electrical stimulation system based on electroactive biomaterials for bone tissue engineering
    2023 114 citations Jiang Ouyang, Tian Xie et al. profile →
  26. Chemically Modified Platforms for Better RNA Therapeutics
    2024 73 citations Yesi Shi, Xueyan Zhen et al. profile →
  27. Clinical advances of mRNA vaccines for cancer immunotherapy
    2025 32 citations Alexey V. Yaremenko, Muhammad Muzamil Khan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Tao China 91 12.9k 9.3k 7.8k 7.1k 2.3k 273 26.1k
Lin Mei China 73 9.8k 0.8× 6.0k 0.6× 5.4k 0.7× 7.0k 1.0× 1.4k 0.6× 276 20.0k
Youqing Shen China 86 11.8k 0.9× 8.4k 0.9× 6.4k 0.8× 10.2k 1.4× 1.2k 0.5× 642 29.1k
Xing‐Jie Liang China 99 15.7k 1.2× 12.7k 1.4× 10.3k 1.3× 10.0k 1.4× 2.1k 0.9× 472 33.3k
Jinjun Shi United States 66 9.3k 0.7× 8.4k 0.9× 4.7k 0.6× 6.9k 1.0× 2.3k 1.0× 138 20.2k
Guangjun Nie China 87 10.2k 0.8× 10.8k 1.2× 5.1k 0.7× 5.7k 0.8× 3.4k 1.4× 355 24.6k
Xiangliang Yang China 85 11.4k 0.9× 7.2k 0.8× 6.5k 0.8× 6.4k 0.9× 1.9k 0.8× 510 25.5k
Daxiang Cui China 85 16.1k 1.2× 9.7k 1.0× 11.8k 1.5× 5.4k 0.8× 954 0.4× 581 29.8k
Twan Lammers Germany 85 12.1k 0.9× 7.3k 0.8× 4.1k 0.5× 10.5k 1.5× 2.2k 0.9× 332 24.8k
Xiangyang Shi China 90 14.0k 1.1× 8.9k 1.0× 8.0k 1.0× 12.6k 1.8× 1.1k 0.5× 605 29.8k
Hao Wang China 74 8.3k 0.6× 7.2k 0.8× 5.7k 0.7× 5.8k 0.8× 1.7k 0.7× 702 22.3k

Countries citing papers authored by Wei Tao

Since Specialization
Citations

This map shows the geographic impact of Wei Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Tao more than expected).

Fields of papers citing papers by Wei Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Tao. The network helps show where Wei Tao may publish in the future.

Co-authorship network of co-authors of Wei Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Tao. A scholar is included among the top collaborators of Wei Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Tao. Wei Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhen, Xueyan, Wei Chen, & Wei Tao. (2025). mRNA-based technology for engineered regenerative medicine. 2(1). 100185–100185. 1 indexed citations
2.
Li, Yongjiang, Zhuoming Zhou, Qimanguli Saiding, et al.. (2025). Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy. Science Advances. 11(21). eadw7191–eadw7191. 6 indexed citations
3.
LIU, Chuang, Xiangang Huang, Kok‐Siong Chen, et al.. (2025). Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles. Nature Nanotechnology. 20(10). 1526–1538. 7 indexed citations
4.
Huang, Xiangang, Chuang LIU, Xinru You, et al.. (2025). Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease. Science Translational Medicine. 17(807). eadu1493–eadu1493. 3 indexed citations
5.
Song, Dan, Wei Tao, Zhuo Tang, & Xuefeng Hu. (2024). Conductive electronic skin coupled with iontophoresis for sensitive skin treatment. Journal of Drug Delivery Science and Technology. 95. 105650–105650. 3 indexed citations
6.
Liu, Ziwei, Fan Xiao, Wei Tao, et al.. (2024). Unleashing the potential: integrating nano-delivery systems with traditional Chinese medicine. Nanoscale. 16(18). 8791–8806. 7 indexed citations
7.
Saiding, Qimanguli, Duotian Qin, Soohwan An, et al.. (2024). Therapeutic nucleic acids in regenerative medicine and tissue repair. Nano Research. 17(10). 8942–8976. 5 indexed citations
8.
Zhao, Nan, Xiaowei Ma, Qimanguli Saiding, et al.. (2024). Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases. Advanced Science. 11(32). e2403399–e2403399. 35 indexed citations
9.
Yue, Jiguang, et al.. (2023). A review of digital twin technology for electromechanical products: Evolution focus throughout key lifecycle phases. Journal of Manufacturing Systems. 70. 264–287. 27 indexed citations
10.
Nie, Yichu, Wei Chen, Yong Kang, et al.. (2023). Two-dimensional porous vermiculite-based nanocatalysts for synergetic catalytic therapy. Biomaterials. 295. 122031–122031. 44 indexed citations
11.
Chen, Shuying, Xiangang Huang, Yonger Xue, et al.. (2023). Nanotechnology-based mRNA vaccines. Nature Reviews Methods Primers. 3(1). 98 indexed citations
12.
Tao, Wei, et al.. (2023). Prediction of Acute Kidney Injury by Fibroblast Growth Factor 23 (FGF-23) in Adult Patients, A Meta-analysis Study.. PubMed. 17(1). 1–8. 1 indexed citations
13.
Wang, Zhenfeng, Yong Yan, Chao Li, et al.. (2022). Fluidity-Guided Assembly of Au@Pt on Liposomes as a Catalase-Powered Nanomotor for Effective Cell Uptake in Cancer Cells and Plant Leaves. ACS Nano. 16(6). 9019–9030. 42 indexed citations
14.
Liu, Yuan, Junqing Wang, Qingqing Xiong, et al.. (2020). Nano–Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection. Accounts of Chemical Research. 54(2). 291–301. 122 indexed citations
15.
Xie, Angel, Sumaira Hanif, Jiang Ouyang, et al.. (2020). Stimuli-responsive prodrug-based cancer nanomedicine. EBioMedicine. 56. 102821–102821. 139 indexed citations
16.
Saw, Phei Er, Herui Yao, Chunhao Lin, et al.. (2019). Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano Letters. 19(9). 5967–5974. 115 indexed citations
17.
Zhu, Xianbing, Xiaoyuan Ji, Na Kong, et al.. (2018). Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy. ACS Nano. 12(3). 2922–2938. 194 indexed citations
18.
Ling, Xiang, Xing Chen, Imogen A. Riddell, et al.. (2018). Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Letters. 18(7). 4618–4625. 183 indexed citations
19.
Xu, Xiaoding, Jun Wu, Yanlan Liu, et al.. (2017). Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. ACS Nano. 11(3). 2618–2627. 181 indexed citations
20.
Tao, Wei, Xiaoyuan Ji, Xiaoding Xu, et al.. (2017). Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy. Angewandte Chemie. 129(39). 12058–12062. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Mei Breakdown of academic impact, for papers by Youqing Shen Breakdown of academic impact, for papers by Xing‐Jie Liang Breakdown of academic impact, for papers by Jinjun Shi Breakdown of academic impact, for papers by Guangjun Nie Breakdown of academic impact, for papers by Xiangliang Yang Breakdown of academic impact, for papers by Daxiang Cui Breakdown of academic impact, for papers by Twan Lammers Breakdown of academic impact, for papers by Xiangyang Shi Breakdown of academic impact, for papers by Hao Wang
Rankless by CCL
2026